ubmslateOT-logo-ubm

OT mobile menu

Topics:

Home

May is National Cancer Research Month

The American Association for Cancer Research presented data on Merkel cell carcinoma at their annual meeting in New Orleans. Image © jovan vitanovski/Shutterstock.com

Recent Content

The UV radiation resistance-associated tumor suppressor gene coordinates DNA repair and might predict skin cancer risk, according to research published in the journal Molecular Cell.

It now turns out that Bim, a downstream signaling molecule of the PD-1 pathway, may hold the clue to which patients may be successful on immunotherapy for metastatic melanoma.

While metabolic pathways in breast cancer have been difficult to identify, researchers at the University of California Berkeley have discovered a new target in triple-negative breast cancer.

Researchers at Weill Cornell Medicine recently published a study in Nature Communications explaining that the rate at which genetically mutated cancer cells grow may help explain why some CLL patients develop treatment resistance.

A new study published in Nature Communications is suggesting that castration-resistant prostate cancer has particular metabolic characteristics that may open new possibilities for treatment.

The US Food and Drug Administration (FDA) granted accelerated approval of nivolumab (Opdivo) based on overall response rate (ORR) in classical Hodgkin lymphoma patients.

The fatty acid DHA, a component of fish oil, might enhance regorafenib’s ability to slow angiogenesis and tumor growth in renal cell carcinoma.

By clicking Accept, you agree to become a member of the UBM Medica Community.